How Long Does CJC-1295 + Ipamorelin Last? Shelf Life & Stability
"Stable" is meaningless without saying stable against what. CJC-1295 + Ipamorelin has its own set of degradation routes, and they determine which storage precautions actually matter for it.
In plain English
The defining thing about a blend is that its ingredients break down independently and at different speeds. So its usable life is set by whichever fails first — a minimum, not an average. Once one component has degraded, the preparation is no longer what it was.
What CJC-1295 + Ipamorelin actually is
This is a blend of two separate molecules rather than one. CJC-1295 is a shortened version of the natural growth hormone signal with four amino acids swapped for resistance. Ipamorelin works through a completely different receptor. They are paired because they reach the same result by two independent routes.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Degradation routes specific to CJC-1295 + Ipamorelin
- Independent degradation of the two components at different rates, which is the defining stability characteristic of any blend.
- Oxidation at aromatic residues in the Ipamorelin component.
- Deamidation and aggregation routes applicable to the longer CJC-1295 chain.
The key handling implication of a blend is that its stability window is not an average — it is the minimum across components. Apply the more conservative of the two profiles.
Freeze–thaw tolerance
Aliquot on reconstitution. In a blend, each component degrades on its own schedule, so the practical shelf life is set by whichever fails first.
How storage addresses these routes
Practical window once reconstituted: 2–3 weeks at 2–8 °C — governed by the shorter-lived component. Protect from light.
Full CJC-1295 + Ipamorelin storage conditionsWhat CJC-1295 + Ipamorelin is studied for
GHRH-receptor and ghrelin-receptor agonism act through different mechanisms, which is the rationale for pairing them.
Developed specifically for GH release with minimal cortisol and prolactin effects — its defining pharmacological feature.
Studied for effects on the pattern of GH secretion rather than continuous elevation.
A common endpoint in the preclinical literature for GH-axis compounds.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More CJC-1295 + Ipamorelin reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Stability reference for other compounds
CJC-1295 + Ipamorelin is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.